Establishment of PLAFMCi005-A induced pluripotent stem cells derived from PBMC from a patient with renal cysts and diabetes syndrome

Establishment of PLAFMCi005-A induced pluripotent stem cells derived from PBMC from a patient with renal cysts and diabetes syndrome

Renal cysts and diabetes syndrome (RCAD) is caused by gene mutations in hepatocyte nuclear factor 1-β (HNF1B), but the underlying molecular mechanism is still unclear. This study established PLAFMCi005-A human induced pluripotent stem cells (iPSCs) by reprogramming peripheral blood mononuclear cells...

Full description

Bibliographic Details
Main Authors:	Shaoyuan Cui, Shunlai Shang, Shuwei Duan, Lingling Wu, Bo Fu, Xueyuan Bai, Qinggang Li, Xiangmei Chen
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506121003329

Similar Items

Establishment of PLAFMCi007-A, an induced pluripotent stem cell line, from peripheral blood mononuclear cells (PBMCs) of a healthy adult woman
by: Meihan Shi, et al.
Published: (2022-05-01)

Establishment of the induced pluripotent stem cell line PLAFMCi006-A from peripheral blood mononuclear cells of polycystic kidney disease patients with PKD2 gene mutation
by: Yuxiang Ma, et al.
Published: (2022-04-01)

Generation of induced pluripotent stem cell PLAFMCi002-A derived from peripheral blood mononuclear cells of polycystic kidney disease patient with PKD1 mutation
by: Tao Wang, et al.
Published: (2020-12-01)

Generation of induced pluripotent stem cells from peripheral blood mononuclear cells obtained from an adult with autosomal recessive polycystic kidney disease
by: Mingyang Sun, et al.
Published: (2022-05-01)

Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice
by: Keng Chen, et al.
Published: (2022-09-01)

A Novel Gene CDC27 Causes SLE and Is Associated With the Disease Activity
by: Shunlai Shang, et al.
Published: (2022-03-01)

Establishment of an integration-free induced pluripotent stem cell line (MUSIi005-A) from exfoliated renal epithelial cells
by: Bootsakorn Boonkaew, et al.
Published: (2018-07-01)

Establishment of induced pluripotent stem cells IRMBi005-A from a patient with sporadic Alzheimer’s disease
by: C. Clua Provost, et al.
Published: (2023-10-01)

Establishment of an induced pluripotent stem cell line DHMi005-A from a healthy male proband
by: M. Dreßen, et al.
Published: (2022-03-01)

Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
by: Shunlai Shang, et al.
Published: (2022-08-01)

Chinese Herbal Formula Shenyi Improves Kidney Injury and Inhibits the Activation of the Alternative Complement Pathway in a Mouse Model of Lupus Nephritis
by: Keng CHEN, Yiyao DENG, Shunlai SHANG, Qinggang LI, Xiangmei CHEN
Published: (2022-09-01)

Establishment of two induced pluripotent stem cell line from healthy elderly (IPTi005-A and IPTi007-A)
by: Lin Zhang, et al.
Published: (2020-05-01)

Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi005-A) from a healthy female Chinese Han
by: Wenzhu Liu, et al.
Published: (2024-06-01)

Generation of iPSC from peripheral blood mononuclear cells obtained from a patient with TSC2-PKD1 contiguous gene deletion syndrome
by: Jian Li, et al.
Published: (2021-03-01)

An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor
by: Jing Shao, et al.
Published: (2024-06-01)

Generation of three human induced pluripotent stem cell sublines (UCLAi005-A, UCLAi005-B and UCLAi005-C) for reproductive science research
by: Erica C. Pandolfi, et al.
Published: (2021-07-01)

Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene
by: Haiyan Zhang, et al.
Published: (2019-10-01)

Generation of human-induced pluripotent stem cell line from PBMC of healthy donor using integration-free Sendai virus technology
by: Jaganmay Sarkar, et al.
Published: (2024-06-01)

Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next‐generation sequencing technology
by: Tao Wang, et al.
Published: (2019-06-01)

Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene
by: Judit Domingo-Prim, et al.
Published: (2019-07-01)

Generation of Mesenchymal Stromal Cells with Low Immunogenicity from Human PBMC-Derived β2 Microglobulin Knockout Induced Pluripotent Stem Cells
by: Shijun Zha, et al.
Published: (2020-11-01)

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma
by: Ji-Hea Kim, et al.
Published: (2022-12-01)

Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy
by: Chi Zhang, et al.
Published: (2022-01-01)

Generation of four induced pluripotent stem cells lines from PBMC of the DFNA58 family members: Two hearing-impaired duplication carriers (USPi006-A e USPi007-A) and two normal-hearing noncarriers (USPi004-A and USPi005-A)
by: Gerson S. Kobayashi, et al.
Published: (2023-09-01)

Novel method for the genomic analysis of PKD1 mutation in autosomal dominant polycystic kidney disease
by: Shunlai Shang, et al.
Published: (2023-01-01)

Generation of two induced pluripotent stem cell lines (FAMRCi005-A and FAMRCi005-B) from patient carrying genetic variant LMNA p.Asp357Val.
by: Polina Klauzen, et al.
Published: (2020-03-01)

Derivation of an aged mouse induced pluripotent stem cell line, IISHDOi005-A
by: María del Carmen Ortuño-Costela, et al.
Published: (2019-04-01)

Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome
by: Yi-bo Wang, et al.
Published: (2024-03-01)

Generation of an induced pluripotent stem cell JTUi005-A from a patient with neuronal intranuclear inclusion disease
by: Yuwen Cao, et al.
Published: (2022-12-01)

Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia
by: Cristiana Barbati, et al.
Published: (2022-05-01)

Differential micro RNA expression in PBMC from multiple sclerosis patients.
by: David Otaegui, et al.
Published: (2009-07-01)

Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors
by: Eddy Quelennec, et al.
Published: (2020-10-01)

Immunological Landscapes in Lung Transplantation: Insights from T Cell Profiling in BAL and PBMC
by: Tharushi Ayanthika de Silva, et al.
Published: (2024-02-01)

Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line (CSUXHi005-A) from human urine epithelial cells
by: Lang He, et al.
Published: (2021-05-01)

Generation of an induced pluripotent stem cell line SDUBMSi005-A from a patient with double primary gastric and colon carcinoma
by: Yan Li, et al.
Published: (2021-05-01)

Establishment of a human induced pluripotent stem cell line, KMUGMCi005-A, from a patient with Epidermodysplasia verruciformis (EV) bearing homozygous splicing donor site mutation in the TMC8 gene
by: Hiroki Ura, et al.
Published: (2022-10-01)

Comparative transcriptome analysis of PBMC from HIV patients pre- and post-antiretroviral therapy
by: Zhao, F, et al.
Published: (2017)

CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production
by: Julieta Abraham-Miranda, et al.
Published: (2022-09-01)

Establishment of the iPSC line CUIMCi005-A from a patient with Stargardt disease for retinal organoid culture
by: Pei-Yin Su, et al.
Published: (2022-12-01)

Identification of PBMC-expressed miRNAs for rheumatoid arthritis
by: Xiaowei Zhu, et al.
Published: (2020-04-01)